Higher cardiovascular mortality with sertindole in ADROIT: a signal not confirmed

ISSN： 1365-1501

Source： International Journal of Psychiatry in Clinical Practice, Vol.6, Iss.1, 2002-12, pp. : 3-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In vivo cardiovascular effects of the new atypical neuroleptic sertindole

By Agelink Marcus W Zeit Thomas Baumann Bruno Majewski Thomas Lemmer Wimar Postert Thomas Lukas Katrin Klieser Eckhard

International Journal of Psychiatry in Clinical Practice, Vol. 5, Iss. 1, 2001-03 ,pp. : 33-40

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Post-marketing surveillance of sertindole

By Toumi Mondher

International Journal of Psychiatry in Clinical Practice, Vol. 6, Iss. 1, 2002-12 ,pp. : 33-35

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Sertindole: cardiac electrophysiological profile

By Haverkamp W Eckardt L Matz J Frederiksen K

International Journal of Psychiatry in Clinical Practice, Vol. 6, Iss. 1, 2002-12 ,pp. : 11-20

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Sertindole: safety and tolerability profile

By Kasper S

International Journal of Psychiatry in Clinical Practice, Vol. 6, Iss. 1, 2002-12 ,pp. : 27-32

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Sertindole: a clinical efficacy profile

By Hale A

International Journal of Psychiatry in Clinical Practice, Vol. 6, Iss. 1, 2002-12 ,pp. : 21-26

Ashgate Publishing Ltd

Access to resources Recommend Favorite